placeholder image
P. R. Heaton All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among adults infected with SARS-CoV-2 JN.1 and XBB-lineage variants. 
    Frontiers in Immunology. 2025
  • 18 Years - VISION and IVY Networks, September 2023-January 2024. 
    MMWR: Morbidity and Mortality Weekly Report. 2024
  • Interim estimates of 2023-24 seasonal influenza vaccine effectiveness - United States. 
    MMWR: Morbidity and Mortality Weekly Report. 2024
  • Reduced likelihood of hospitalization with the JN.1 or HV.1 severe acute respiratory syndrome coronavirus 2 variants compared with the EG.5 variant. 
    Journal of Infectious Diseases. 2024
  • SARS-CoV-2 antiviral prescribing gaps among non-hospitalized high-risk adults. 
    Clinical Infectious Diseases. 2024
  • Use of next-generation sequencing to detect mutations associated with antiviral drug resistance in cytomegalovirus. 
    Journal of Clinical Microbiology. 2023
  • Streptobacillus moniliformis with features of hemophagocytic lymphohistiocytosis identified by direct sequencing. 
    Pediatric Infectious Disease Journal. 2020
    • Webpage
  • Technical briefing 5: SARS-CoV-2 antiviral treatment gaps
    2023
    • Contact
    full name
  • P. R. Heaton
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration